Abstract
Obesity is, in part, a result of positive energy balance or energy intake exceeding physiological needs. Excess energy intake is determined by a series of food choices over time. These choices involve both motivational and executive function processes. Problems arise when there is excessive motivation to eat and low impulse control, a situation we have termed reinforcement pathology. Motivational and executive function processes have also been implicated in the development of drug dependence and addiction. In this review we discuss the application of reinforcement pathology to obesity, and implications of this approach for obesity treatment.
Keywords: Behavioral economics, delay discounting, impulsivity, obesity, reinforcement pathology, reinforcing value, dopamine, drug dependence, dual systems hypothesis, behavioral intervention
Current Drug Abuse Reviews
Title: Reinforcement Pathology and Obesity
Volume: 4 Issue: 3
Author(s): Katelyn A. Carr, Tinuke Oluyomi Daniel, Henry Lin and Leonard H. Epstein
Affiliation:
Keywords: Behavioral economics, delay discounting, impulsivity, obesity, reinforcement pathology, reinforcing value, dopamine, drug dependence, dual systems hypothesis, behavioral intervention
Abstract: Obesity is, in part, a result of positive energy balance or energy intake exceeding physiological needs. Excess energy intake is determined by a series of food choices over time. These choices involve both motivational and executive function processes. Problems arise when there is excessive motivation to eat and low impulse control, a situation we have termed reinforcement pathology. Motivational and executive function processes have also been implicated in the development of drug dependence and addiction. In this review we discuss the application of reinforcement pathology to obesity, and implications of this approach for obesity treatment.
Export Options
About this article
Cite this article as:
A. Carr Katelyn, Oluyomi Daniel Tinuke, Lin Henry and H. Epstein Leonard, Reinforcement Pathology and Obesity, Current Drug Abuse Reviews 2011; 4 (3) . https://dx.doi.org/10.2174/1874473711104030190
DOI https://dx.doi.org/10.2174/1874473711104030190 |
Print ISSN 1874-4737 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4745 |
Related Articles
-
Bacterial Protein Interaction Networks: Connectivity is Ruled by Gene Conservation, Essentiality and Function
Current Genomics Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Recent Patents on Positive Allosteric Modulators of the Metabotropic Glutamate 5 Receptor as a Potential Treatment for Schizophrenia
Recent Patents on CNS Drug Discovery (Discontinued) Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases
Current Neuropharmacology Toward a Molecular Understanding of the Interaction of Dual Specificity Phosphatases with Substrates: Insights from Structure-Based Modeling and High Throughput Screening
Current Medicinal Chemistry New Trends in the Treatment of Schizophrenia
CNS & Neurological Disorders - Drug Targets Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)
CNS & Neurological Disorders - Drug Targets Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population
Current Alzheimer Research Editorial [Hot topic: Recent Advances in the Medicinal Radiochemistry of Radioligands for Cerebral In Vivo Imaging (Guest Editors: Andrew G. Horti and Robert F. Dannals)]
Current Topics in Medicinal Chemistry Heterocyclic Dications as a New Class of Telomeric G-Quadruplex Targeting Agents
Current Pharmaceutical Design Psychotherapy for Pregnant Women with Schizophrenia
Current Women`s Health Reviews Cinnamate Hybrids: A Unique Family of Compounds with Multiple Biological Activities
Current Pharmaceutical Biotechnology Monoclonal Antibodies as Pharmacokinetic Antagonists for the Treatment of (+)-Methamphetamine Addiction
CNS & Neurological Disorders - Drug Targets Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Current Medicinal Chemistry Cognitive Performance and Neuro-Metabolites in HIV Using 3T Magnetic Resonance Spectroscopy: A Cross-Sectional Study from India
Current HIV Research Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands
Current Topics in Medicinal Chemistry Recent Developments in Neurochemical Imaging in Schizophrenia: An Update
Current Medicinal Chemistry A Perspective in Renewable Energy Production from Biomass Pyrolysis - Challenges and Prospects
Current Organic Chemistry Meet Our Managing Editor:
Neuroscience and Biomedical Engineering (Discontinued) Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior
Current Neuropharmacology